SPTX
SPTX
US81221K1088
Seaport Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
87.294.000 52.416.000
66.5%
Operating Income -87.294.000 -52.416.000
66.5%
Pretax Income -74.108.000 -46.879.000
58.1%
Net Income Common Stockholders -74.881.000 -46.879.000
59.7%
-- --
--
-- --
--
ende